XT
XTX Topco’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,488
| Closed | -$402K | – | 2310 |
|
|
2025
Q1 | $402K | Buy |
+1,488
| New | +$402K | 0.02% | 1190 |
|
|
2024
Q3 | – | Sell |
-1,480
| Closed | -$360K | – | 2041 |
|
|
2024
Q2 | $360K | Sell |
1,480
-3,325
| -69% | -$808K | 0.03% | 846 |
|
|
2024
Q1 | $718K | Buy |
+4,805
| New | +$718K | 0.1% | 286 |
|
|
2023
Q4 | – | Sell |
-8,836
| Closed | -$1.56M | – | 1543 |
|
|
2023
Q3 | $1.56M | Buy |
8,836
+4,332
| +96% | +$767K | 0.27% | 27 |
|
|
2023
Q2 | $855K | Buy |
+4,504
| New | +$855K | 0.15% | 132 |
|
|
2022
Q4 | – | Sell |
-3,884
| Closed | -$777K | – | 1091 |
|
|
2022
Q3 | $777K | Buy |
+3,884
| New | +$777K | 0.19% | 91 |
|
|
2022
Q2 | – | Sell |
-1,497
| Closed | -$244K | – | 828 |
|
|
2022
Q1 | $244K | Buy |
+1,497
| New | +$244K | 0.11% | 341 |
|